Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Idris Tolgay Ocal"'
Autor:
Sunil S. Badve, Sanghee Cho, Xiaoyu Lu, Sha Cao, Soumya Ghose, Aye Aye Thike, Puay Hoon Tan, Idris Tolgay Ocal, Daniele Generali, Fabrizio Zanconati, Adrian L. Harris, Fiona Ginty, Yesim Gökmen-Polar
Publikováno v:
Cancers; Volume 14; Issue 16; Pages: 3916
Tumor-infiltrating lymphocytes (TILs) are prognostic in invasive breast cancer. However, their prognostic significance in ductal carcinoma in situ (DCIS) has been controversial. To investigate the prognostic role of TILs in DCIS outcome, we used diff
Autor:
Martha C. Wasserman, Robert W. Maxwell, Kristin A. Robinson, Idris Tolgay Ocal, Santo Maimone
Publikováno v:
Journal of Breast Imaging. 2:330-335
Objective Parenchymal breast cysts are considered to be rare in men and are sparsely described in the literature. The purpose of this study was to review our institution’s experience with male breast cysts in an effort to improve overall understand
Autor:
Shi Wei, Richard Schwab, Gregor Krings, Lajos Pusztai, Rashmi Krishna Murthy, Lauren LeBeau, Megan L. Troxell, Adam Asare, Erin D. Ellis, Sharon Sams, Donald A. Berry, Fang Fan, Anne M. Wallace, Andres Forero-Torres, Christina Yau, Angela DeMichele, Donald W. Northfelt, Mara H. Rendi, Laila Khazai, Husain Sattar, Xiuzhen Duan, Ronald Balassanian, Rebecca K. Viscusi, Hyo S. Han, Barbara A. Parker, A. Jo Chien, Brian Leyland-Jones, Meredith Buxton, Idris Tolgay Ocal, Yunn Yi Chen, Qamar J. Khan, Brian Datnow, Barbara Haley, Tuyethoa Vinh, Kathy S. Albain, Laura van 't Veer, Minetta C. Liu, Michael Feldman, Amy S. Clark, Kirsten H. Edmiston, W. Fraser Symmans, Sonal Shad, Kathleen Kemmer, Judy C. Boughey, Julie E. Lang, Paulette Mhawech-Fauceglia, Teresa Helsten, Douglas Yee, Molly Klein, Rita Nanda, Claudine Isaacs, Anthony D. Elias, Sara J. Venters, Nola M. Hylton, Jay Zeck, Laura J. Esserman, Beiyun Chen, Hope S. Rugo, Smita Asare, Sunati Sahoo, Jeffrey B. Matthews, Jane Perlmutter
Publikováno v:
JAMA Oncol
Importance Residual cancer burden (RCB) distributions may improve the interpretation of efficacy in neoadjuvant breast cancer trials. Objective To compare RCB distributions between randomized control and investigational treatments within subtypes of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::970e2b28a3f16ef394eea6cc208edc54
https://europepmc.org/articles/PMC8446908/
https://europepmc.org/articles/PMC8446908/
Autor:
Richard Gray, Roxanne Lorans, Patricia A. Cronin, Nabil Wasif, Bhavika K. Patel, Victor J. Pizzitola, Anamika Basu, Idris Tolgay Ocal, Heidi E. Kosiorek, Ann E. McCullough, William W. Sheaffer, Chee Chee H. Stucky, Marina E. Giurescu, Barbara A. Pockaj
Publikováno v:
The American Journal of Surgery. 217:1025-1029
Background Upstaging from DCIS to invasive ductal carcinoma varies widely from 0 to 59%. We aim to identify risk factors associated with upstaging in all DCIS patients and based on specific surgical intervention. Methods Patients with a pre-operative
Autor:
Beiyun Chen, William R. Sukov, Idris Tolgay Ocal, Reid G. Meyer, Grant M. Spears, Katherine B. Geiersbach, Taofic Mounajjed, Jason A. Yuhas, Kristina M. Del Rosario, Robert B. Jenkins, Daniel R. Sill
Publikováno v:
American journal of clinical pathology. 156(5)
Objectives We investigated the impact of our laboratory’s reflex testing process for resolving ERBB2 (HER2) status on breast cancer samples that require additional workup after fluorescence in situ hybridization (FISH), per guideline recommendation
Publikováno v:
Skeletal radiology. 50(9)
Autor:
Aziza Nassar, Idris Tolgay Ocal, Sotiris Sotiriou, Paul A. Decker, Sejal Subhash Shah, Antonis Kourtidis, Panos Z. Anastasiadis, Mary T. Haddad, Ryan W. Feathers, Lindy J. Pence
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 1275, p 1275 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 3
International Journal of Molecular Sciences
Volume 22
Issue 3
Background: Inflammatory breast cancer is a highly aggressive form of breast cancer that robustly forms clusters of tumor emboli in dermal lymphatics and readily metastasizes. Inflammatory breast cancers express high levels of E-cadherin, the major p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c062f6814f5a9b5fb0f35a415ae3cc7
https://doi.org/10.21203/rs.3.rs-57687/v1
https://doi.org/10.21203/rs.3.rs-57687/v1
Autor:
Heidi E. Kosiorek, Patricia A. Cronin, Idris Tolgay Ocal, Taylor H. Parnall, Barbara A. Pockaj, Jacob B. Hammond, Ann E. McCullough, Donald W. Northfelt, Brenda Ernst, Derek W. Scott
Publikováno v:
Journal of surgical oncologyREFERENCES.
Background and objectives Neoadjuvant endocrine therapy (NET) for ER+ breast cancer can downstage primary tumors. We evaluated NET efficacy in node-positive patients. Methods Node-positive patients undergoing NET for ER+ breast cancer from 2012 to 20
Autor:
Codrin Iacob, M. Kurli, Idris Tolgay Ocal, Alan H. Bryce, Leslie J Padrnos, Odette M. Houghton
Publikováno v:
Melanoma research. 30(6)
Cutaneous melanoma metastases can contribute to visual disturbances through a variety of factors, including metastasis to the vitreal fluid. The optimum management of metastatic cutaneous melanoma to the vitreal fluid is unknown, but can include radi
Autor:
M Sugi, Donald W. Northfelt, Talal Hilal, Bhavika K. Patel, Idris Tolgay Ocal, Nan Zhang, Barbara A. Pockaj, Matthew F. Covington
Publikováno v:
Cancer Research. 78:PD2-11
OBJECTIVE: Currently, no study has assessed the performance of contrast-enhanced spectral mammography (CESM) in evaluating tumor response in breast cancer patients undergoing neoadjuvant systemic therapy (NST). This study aims to evaluate whether the